Evaluation of Sarcopenia in Older Patients Undergoing Head and Neck Cancer Surgery.


Journal

The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378

Informations de publication

Date de publication:
02 2022
Historique:
revised: 13 07 2021
received: 27 03 2021
accepted: 17 07 2021
pubmed: 13 8 2021
medline: 19 2 2022
entrez: 12 8 2021
Statut: ppublish

Résumé

Sarcopenia is a hallmark of aging and its identification may help predict adverse postoperative events in patients undergoing head and neck surgery. The study objective was to assess the relationship between sarcopenia and postoperative complications and length of stay in patients undergoing major head and neck cancer surgery. Prospective cohort study. A prospective cohort study was performed of patients 50 years and older undergoing major head and neck surgery. Sarcopenia was defined as low muscle mass (determined by neck muscle cross-sectional imaging) with either low muscle strength (grip strength) or low muscle performance (timed walk test). Logistic regression was applied on binary outcomes, and linear regression was used for log-transformed length of hospital stay (LOS). Univariate and multivariate analyses were performed. Of the 251 patients enrolled, pre-sarcopenia was present in 34.9% (n = 87) and sarcopenia in 15.6% (n = 39) of patients. Patients with sarcopenia were more likely to be older (P = .001), female (P = .001), have a lower body mass index (P = .001), and lower preoperative hemoglobin (P < .001). On univariate analysis, the presence and severity of sarcopenia was associated with the development of medical complications (P = .029), higher grade of complications (P = .032), LOS (P = .015), and overall survival (P = .001). On multivariate analysis, sarcopenia was associated with a longer LOS (β = 0.32 [95% CI: 0.19-0.45], P < .001) and worse overall survival (HR = 2.21 [95% CI: 1.01-4.23], P = .017). Sarcopenia may aid in the prediction of prolonged hospital stay and death in patients who are candidates for major head and neck surgery. 3 Laryngoscope, 132:356-363, 2022.

Identifiants

pubmed: 34383321
doi: 10.1002/lary.29782
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

356-363

Informations de copyright

© 2021 The American Laryngological, Rhinological and Otological Society, Inc.

Références

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 2010;39:412-423.
Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019;48:601.
Cho Y, Kim JW, Keum KC, Lee CG, Jeung HC, Lee IJ. Prognostic significance of sarcopenia with inflammation in patients with head and neck cancer who underwent definitive chemoradiotherapy. Front Oncol 2018;8:457.
Chargi N, Bril SI, Emmelot-Vonk MH, de Bree R. Sarcopenia is a prognostic factor for overall survival in elderly patients with head-and-neck cancer. Eur Arch Otorhinolaryngol 2019;276:1475-1486.
Thomas CM, Sklar MC, Su J, et al. Evaluation of older age and frailty as factors associated with depression and postoperative decision regret in patients undergoing major head and neck surgery. JAMA Otolaryngol Head Neck Surg 2019;145:1170-1178.
van Rijn-Dekker MI, van den Bosch L, van den Hoek JGM, et al. Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with radiotherapy. Radiother Oncol 2020;147:103-110.
Hua X, Liu S, Liao J-F, et al. When the loss costs too much: a systematic review and meta-analysis of sarcopenia in head and neck cancer. Front Oncol 2019;9:1561.
Wong A, Zhu D, Kraus D, Tham T. Radiologically defined sarcopenia affects survival in head and neck cancer: a meta-analysis. Laryngoscope 2021;131:333-341.
Goldstein DP, Sklar MC, de Almeida JR, et al. Frailty as a predictor of outcomes in patients undergoing head and neck cancer surgery. Laryngoscope 2020;130:E340-E345.
Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009;250:187-196.
Monteiro E, Sklar MC, Eskander A, et al. Assessment of the Clavien-Dindo classification system for complications in head and neck surgery. Laryngoscope 2014;124:2726-2731.
Swartz JE, Pothen AJ, Wegner I, et al. Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients. Oral Oncol 2016;62:28-33.
Bril SI, Wendrich AW, Swartz JE, et al. Interobserver agreement of skeletal muscle mass measurement on head and neck CT imaging at the level of the third cervical vertebra. Eur Arch Otorhinolaryngol 2019;276:1175-1182.
Wendrich AW, Swartz JE, Bril SI, et al. Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer. Oral Oncol 2017;71:26-33.
Trevino-Aguirre E, López-Teros T, Gutiérrez-Robledo L, Vandewoude M, Pérez-Zepeda M. Availability and use of dual energy X-ray absorptiometry (DXA) and bio-impedance analysis (BIA) for the evaluation of sarcopenia by Belgian and Latin American geriatricians. J Cachexia Sarcopenia Muscle 2014;5:79-81.
Masanes F, Rojano I Luque X, Salvà A, et al. Cut-off points for muscle mass - not grip strength or gait speed - determine variations in sarcopenia prevalence. J Nutr Health Aging 2017;21:825-829.
Buckinx F, Landi F, Cesari M, et al. Pitfalls in the measurement of muscle mass: a need for a reference standard. J Cachexia Sarcopenia Muscle 2018;9:269-278.
Bhasin S, Travison TG, Manini TM, et al. Sarcopenia definition: the position statements of the sarcopenia definition and outcomes consortium. J Am Geriatr Soc 2020;68:1410-1418.
Miller JA, Harris K, Roche C, et al. Sarcopenia is a predictor of outcomes after lobectomy. J Thorac Dis 2018;10:432-440.
Pittelkow EM, DeBrock W, McLaughlin B, et al. Preoperatively identified sarcopenia leads to increased postoperative complications, hospital and ICU length of stay in autologous microsurgical breast reconstruction. J Reconstr Microsurg 2020;36:59-63.
Jung AR, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY. The impact of skeletal muscle depletion on older adult patients with head and neck cancer undergoing primary surgery. J Geriatr Oncol 2021;12:128-133.
Alwani MM, Jones AJ, Novinger LJ, et al. Impact of sarcopenia on outcomes of autologous head and neck free tissue reconstruction. J Reconstr Microsurg 2020;36:369-378.
Achim V, Bash J, Mowery A, et al. Prognostic indication of sarcopenia for wound complication after Total Laryngectomy. JAMA Otolaryngol Head Neck Surg 2017;143:1159-1165.
Fattouh M, Chang GY, Ow TJ, et al. Association between pretreatment obesity, sarcopenia, and survival in patients with head and neck cancer. Head Neck 2019;41:707-714.
Gonzalez MC, Pastore CA, Orlandi SP, Heymsfield SB. Obesity paradox in cancer: new insights provided by body composition. Am J Clin Nutr 2014;99:999-1005.
Abt NB, Richmon JD, Koch WM, Eisele DW, Agrawal N. Assessment of the predictive value of the modified frailty index for Clavien-Dindo grade IV critical care complications in major head and neck cancer operations. JAMA Otolaryngol Head Neck Surg 2016;142:658-664.
Miyamoto S, Nakao J, Higashino T, Yoshimoto S, Hayashi R, Sakuraba M. Clavien-Dindo classification for grading complications after total pharyngolaryngectomy and free jejunum transfer. PLoS One 2019;14:e0222570.
Fu TS, Sklar M, Cohen M, et al. Is frailty associated with worse outcomes after head and neck surgery? A narrative review. Laryngoscope 2020;130:1436-1442.
Vallur S, Dutta A, Arjun AP. Use of Clavien-Dindo classification system in assessing head and neck surgery complications. Indian J Otolaryngol Head Neck Surg 2020;72:24-29.
Levett DZ, Grocott MP. Cardiopulmonary exercise testing, prehabilitation, and enhanced recovery after surgery (ERAS). Can J Anaesth 2015;62:131-142.
Beaudart C, Dawson A, Shaw SC, et al. Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review. Osteoporos Int 2017;28:1817-1833.
Yoshimura Y, Wakabayashi H, Yamada M, Kim H, Harada A, Arai H. Interventions for treating sarcopenia: a systematic review and meta-analysis of randomized controlled studies. J Am Med Dir Assoc 2017;18:553 e1-553 e16.
Valkenet K, van de Port IGL, Dronkers JJ, de Vries WR, Lindeman E, Backx FJG. The effects of preoperative exercise therapy on postoperative outcome: a systematic review. Clin Rehabil 2011;25:99-111.
Hughes MJ, Hackney RJ, Lamb PJ, Wigmore SJ, Christopher Deans DA, Skipworth RJE. Prehabilitation before major abdominal surgery: a systematic review and meta-analysis. World J Surg 2019;43:1661-1668.

Auteurs

Susannah Orzell (S)

Department of Otolaryngology Head and Neck Surgery/Surgical Oncology, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.

Benjamin F J Verhaaren (BFJ)

Department of Radiology, University Hospitals Leuven, Leuven, Belgium.

Rajan Grewal (R)

Department of Otolaryngology Head and Neck Surgery/Surgical Oncology, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.

Michael Sklar (M)

Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada.

Jonathan C Irish (JC)

Department of Otolaryngology Head and Neck Surgery/Surgical Oncology, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.

Ralph Gilbert (R)

Department of Otolaryngology Head and Neck Surgery/Surgical Oncology, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.

Dale Brown (D)

Department of Otolaryngology Head and Neck Surgery/Surgical Oncology, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.

Patrick Gullane (P)

Department of Otolaryngology Head and Neck Surgery/Surgical Oncology, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.

John R de Almeida (JR)

Department of Otolaryngology Head and Neck Surgery/Surgical Oncology, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.

Eugene Yu (E)

Joint Department of Medical Imaging, University Health Network, University of Toronto, Toronto, Ontario, Canada.

Jie Su (J)

Department of Biostatistics, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.

Wei Xu (W)

Department of Biostatistics, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.

Shabbir M H Alibhai (SMH)

Department of Medicine, University Health Network, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

David P Goldstein (DP)

Department of Otolaryngology Head and Neck Surgery/Surgical Oncology, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH